Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleLenvatinib versus Sorafenib as first‐line treatment in hepatocellular carcinoma: A multi‐institutional matched case‐control study.AuthorsRimini, Margherita; Shimose, Shigeo; Lonardi, Sara; Tada, Toshifumi; Masi, Gianluca; Iwamoto, Hideki; Lai, Eleonora; Burgio, Valentina; Hiraoka, Atsushi; Ishikawa, Toru; Soldà, Caterina; Shirono, Tomotake; Vivaldi, Caterina; Takaguchi, Koichi; Shimada, Noritomo; Astara, Giorgio; Koga, Hironori; Nouso, Kazuhiro; Joko, Kouji; Torimura, TakujiPublicationHepatology Research, 2021, Vol 51, Issue 12, p1229ISSN1386-6346Publication typeArticleDOI10.1111/hepr.13718